Neurocrine resubmits Indiplon-MR NDA

NBIX resubmitted an NDA to FDA for Indiplon modified-release (MR) tablets to treat insomnia in adult and elderly patients. The NDA for Indiplon immediate-release (IR) capsules was resubmitted in April...